We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

A 12-Week Safety and Pharmacodynamic Study of AT1001 in Patients With Fabry Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00283959
Recruitment Status : Completed
First Posted : January 31, 2006
Last Update Posted : April 15, 2015
Information provided by (Responsible Party):
Amicus Therapeutics

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : May 2008
  Study Completion Date : May 2008
  Certification or Request for Extension to Delay Results Submission: August 17, 2010